Navellier Services open
ADVERTISEMENT

Navellier Growth

Louis' Blog Archive

179 Trades to Make Before Thanksgiving

November 21, 2016

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 179 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. Read more

Top 7 Economic Reports of the Week

November 18, 2016

It's Friday and that means it's time to review the latest economic data and identify which pockets of the economy are heating up and which are slowing down. Don't worry about catching every headline and every report throughout the week—I recap all of the most important news impacting your wealth right here every Friday. Let's take a look at this week's big headlines… Read more

108 Dividend Stocks You Should Have on Your Radar

November 17, 2016

In this low interest rate environment, dividends are still looking great. But you still have to do your homework and screen dividend stocks for fundamental health. And now is the perfect time to do so because we're coming up on a bunch of ex-dividend dates over the next few weeks...full details here. Read more

Ask Louis: Will the Fed Raise Interest Rates Next Month?

November 16, 2016

Two weeks ago, the Fed announced that decided to keep interest rates unchanged at its November meeting. Since then, a lot has changed. We have a new President-elect, and a slew of new economic reports have been released. Given these changes, how likely is it that the Fed will actually raise rates next month? Let's find out. Read more

Buy This Top Chipmaker Before Thursday

November 15, 2016

I'm counting down the days. After the closing bell rings on Thursday, one of my top technology companies will be reporting its third-quarter operating results. With the stock trading at less than 13 times future earnings, it is a fantastic buy right now. But you'll need to act quickly, because I expect this semiconductor play to surge after earnings. Here are the complete details... Read more

These 119 Big-Name Stocks Are on the Move

November 14, 2016

During these busy times, it pays to stay on top of the latest profit opportunities. And today’s blog post should be a great place to start. After taking a close look at the latest data on institutional buying pressure and each company’s fundamental health, I decided to revise my Portfolio Grader recommendations for 119 big blue chips. Chances are that you have at least one of these stocks in your portfolio, so you may want to give this list a skim and act accordingly. Read more

What's Going on With the Economy?

November 11, 2016

It's Friday and that means it's time to review the latest economic data and identify which pockets of the economy are heating up and which are slowing down. Don't worry about catching every headline and every report throughout the week—I recap all of the most important news impacting your wealth right here every Friday. Let's take a look at this week's big headlines… Read more

Bargain Buys? Kohl's and Macy's Surge After Earnings

November 10, 2016

Today, the retail sector is breathing a sigh of relief. Two of the biggest (and most disappointing) department stores just reported earnings, and the results weren't as bad as analysts feared. Shares of Kohl's Corp. (KSS) and Macy's (M) shot up on the news. Are these earnings reports enough to change my mind on these beaten-down stocks? Let's dig into the details. Read more

A Special Post Election Podcast

November 9, 2016

Well folks, the votes are in, and Donald Trump will become the 45th president of the United States. This was one of the most contentious elections in U.S. history, and the outcome certainly surprised Wall Street, as the benchmark indices opened substantially lower today. It’s never fun to wake up to this kind of drop, and that’s exactly why I’ve recorded this special post-election podcast this morning.

You see, while others are getting caught up in the knee-jerk selling action, I do not recommend following the crowd. The good news is that now that we know who will occupy the White House for the next four years, the recent uncertainty in the markets should finally begin to dissipate.

In this special podcast, I cover the highlights of what all investors need to know about in this post-election environment…

Read more

Avoid These 7 Big-Name Biotechs and Pharmaceuticals

November 8, 2016

This morning, a few biotech and pharmaceutical companies are trending lower–and it's not because of today's election. Weaker-than-expected profits, faltering sales and full-year guidance cuts are weighing on several companies shares, including Valeant Pharmaceuticals (VRX) and Depomed, Inc. (DEPO). In light of these recent results, I thought biotech and pharmaceutical stocks were worth a closer look. And I was right; there are seven big-name biotech and pharmaceutical stocks you should avoid at all costs. Read more

Navellier Toolbox Powered by Portfolio Grader

Rate Your Stocks:

Research Stocks:

By Sector By Fundamentals
lnel_Nov13300x250
ADVERTISEMENT

More Louis Navellier

Twitter

Facebook

RSS Feed

Little Book

InvestorPlace Network

InvestorPlace.com

Options Zone